Breast Cancer
Investigators from University of Sheffield Target Breast Cancer
Published in Women's Health Weekly, March 1st, 2012
2012 MAR 1 -- According to the authors of recent research published in the journal Value in Health, "We report a cost-effectiveness evaluation of granulocyte colony-stimulating factors (G-CSFs) for the prevention of febrile neutropenia (FN) after chemotherapy in the United Kingdom (UK). A mathematical model was constructed simulating the experience of women with breast cancer undergoing chemotherapy."
"Three strategies were modeled: primary prophylaxis (G-CSFs administered in all cycles), secondary prophylaxis (G-CSFs administered in all cycles after an FN event), and no G-CSF prophylaxis. Three G-CSFs were considered: filgrastim, lenograstim, and...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Breast Cancer
AstraZeneca Announces First Direct-to-Patient Program Offering the Brand ARIMIDEX(R) anastrozole Tablets to Patients for Only $40 Per Month - Antibiotics - Antineoplastics
Data from Kumamoto Rousai Hospital Advance Knowledge in Antibiotics - Antineoplastics - Breast Cancer
Data on Breast Cancer Published by Researchers at Rush University Medical Center - Breast Cancer
Data on Breast Cancer Reported by Researchers at Center for Biotechnology - Breast Cancer
Data on Breast Cancer Reported by Researchers at M.D. Anderson Cancer Center - Chlamydia
Data on Chlamydia Discussed by Researchers at University of California - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
